Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 22, 2024
- Accession no.
- 0001415889-24-014099
- Filed
- May 22, 2024
- Trade date
- May 20-21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.98M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | MOption exerciseAcquired | +3,600 | $129.49 | +$466,164 | 3,730 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −1,063 | $273.24F2 | −$290,454.12 | 2,667 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −2,399 | $274.16F3 | −$657,709.84 | 268 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −138 | $274.93F4 | −$37,940.34 | 130 | Direct | |
| May 21, 2024 | Common Stock | MOption exerciseAcquired | +3,600 | $129.49 | +$466,164 | 3,730 | Direct | |
| May 21, 2024 | Common Stock | SSaleDisposed | −902 | $274.70F5 | −$247,779.4 | 2,828 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −1,149 | $275.80F6 | −$316,894.2 | 1,679 | Direct | |
| May 20, 2024 | Common Stock | SSaleDisposed | −983 | $276.53F7 | −$271,828.99 | 696 | Direct | |
| May 21, 2024 | Common Stock | SSaleDisposed | −565 | $277.68F8 | −$156,889.2 | 131 | Direct | |
| May 21, 2024 | Common Stock | SSaleDisposed | −1 | $278.29 | −$278.29 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | MOption exerciseDisposed | −3,600 | $0.00 | $0 | 237,869 | Direct | |
| May 21, 2024 | Common Stock | MOption exerciseDisposed | −3,600 | $0.00 | $0 | 234,269 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $272.68 to $273.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $273.77 to $274.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $274.77 to $275.135. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $274.17 to $275.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $275.195 to $276.165. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $276.195 to $277.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $277.265 to $278.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.